However, VTCN1 negatively regulates T cell-mediated immunity and potentiates immune evasion, epithelial cell transformation, proliferation, cytokine production and the development of cytotoxicity by suppressing T cell activation in the tumour microenvironment. The gene discussed is VTCN1; the disease is neoplasm.